- Zoster (Shingles)
- Immunocompromised Adults
My patient takes rituximab. When is the best time to vaccinate him?
For patients receiving anti-B cell therapies (e.g., rituximab), CDC recommends administering a dose of RZV approximately 4 weeks prior to the next scheduled therapy.
Last reviewed:
March 9, 2022